{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:48:40Z","timestamp":1780397320226,"version":"3.54.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Utrecht"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s11886-018-0953-3","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T06:32:53Z","timestamp":1518417173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["PET Molecular Targets and Near-Infrared Fluorescence Imaging of Atherosclerosis"],"prefix":"10.1007","volume":"20","author":[{"given":"Csilla","family":"Celeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Leiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A. P.","family":"Takx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"key":"953_CR1","unstructured":"Organization WH (2015) Cardiovascular diseases (CVDs). Available via http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/ . Accessed Augus 10, 2017."},{"key":"953_CR2","unstructured":"Organization WH global status report on noncommunicable diseases 2010. Geneva, Switzerland. Available via http:\/\/www.who.int\/nmh\/publications\/ncd_report_full_en.pdf . Accessed August 10, 2017."},{"issue":"8 Suppl","key":"953_CR3","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","volume":"47","author":"E Falk","year":"2006","unstructured":"Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47(8 Suppl):C7\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2005.09.068 .","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"953_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1161\/ATVBAHA.108.180497","volume":"29","author":"A Mantovani","year":"2009","unstructured":"Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol. 2009;29(10):1419\u201323. https:\/\/doi.org\/10.1161\/ATVBAHA.108.180497 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"953_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","volume":"28","author":"AC Doran","year":"2008","unstructured":"Doran AC, Meller N, Mcnamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28(5):812\u20139. https:\/\/doi.org\/10.1161\/ATVBAHA.107.159327 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"953_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","volume":"145","author":"KJ Moore","year":"2011","unstructured":"Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011;145(3):341\u201355. https:\/\/doi.org\/10.1016\/j.cell.2011.04.005 .","journal-title":"Cell"},{"issue":"8 Suppl","key":"953_CR7","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006;47(8 Suppl):C13\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2005.10.065 .","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"953_CR8","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jacc.2006.05.076","volume":"48","author":"A Tawakol","year":"2006","unstructured":"Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48(9):1818\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2006.05.076 .","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"953_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2967\/jnumed.110.080838","volume":"52","author":"HJ Yoo","year":"2011","unstructured":"Yoo HJ, Kim S, Park MS, Yang SJ, Kim TN, Seo JA, et al. Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET. J Nucl Med. 2011;52(1):10\u20137. https:\/\/doi.org\/10.2967\/jnumed.110.080838 .","journal-title":"J Nucl Med"},{"issue":"12","key":"953_CR10","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.2967\/jnumed.113.119602","volume":"54","author":"TS Noh","year":"2013","unstructured":"Noh TS, Moon SH, Cho YS, Hong SP, Lee EJ, Choi JY, et al. Relation of carotid artery 18F-FDG uptake to C-reactive protein and Framingham risk score in a large cohort of asymptomatic adults. J Nucl Med. 2013;54(12):2070\u20136. https:\/\/doi.org\/10.2967\/jnumed.113.119602 .","journal-title":"J Nucl Med"},{"issue":"2","key":"953_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCIMAGING.109.888909","volume":"3","author":"TN Kim","year":"2010","unstructured":"Kim TN, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, et al. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging. 2010;3(2):142\u20138. https:\/\/doi.org\/10.1161\/CIRCIMAGING.109.888909 .","journal-title":"Circ Cardiovasc Imaging"},{"issue":"14","key":"953_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1161\/CIRCULATIONAHA.106.646380","volume":"114","author":"M Nahrendorf","year":"2006","unstructured":"Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114(14):1504\u201311. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.646380 .","journal-title":"Circulation"},{"issue":"1","key":"953_CR13","doi-asserted-by":"publisher","first-page":"21785","DOI":"10.1038\/srep21785","volume":"6","author":"RY Khamis","year":"2016","unstructured":"\u2022\u2022 Khamis RY, Woollard KJ, Hyde GD, Boyle JJ, Bicknell C, Chang SH, et al. Near infrared fluorescence (NIRF) molecular imaging of oxidized LDL with an autoantibody in experimental atherosclerosis. Sci Rep. 2016;6(1):21785. Relevant NIRF study, which demonstrates the feasibility of a NIRF dye-labeled autoantibody to detect oxidized LDL as a prime target of atherosclerosis. https:\/\/doi.org\/10.1038\/srep21785 .","journal-title":"Sci Rep"},{"key":"953_CR14","doi-asserted-by":"crossref","unstructured":"\u2022 Stein-Merlob AF, Hara T, Mccarthy JR, et al., Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging. Circ Cardiovasc Imaging. 2017;10(5). A study about a NIRF-derivatized nanoparticle, which identifies decreased endothelial permeability as an early sign of superficial erosion.","DOI":"10.1161\/CIRCIMAGING.116.005813"},{"issue":"20","key":"953_CR15","doi-asserted-by":"publisher","first-page":"e534","DOI":"10.1161\/CIRCULATIONAHA.108.821389","volume":"119","author":"BM Wallis De Vries","year":"2009","unstructured":"Wallis De Vries BM, Hillebrands JL, Van Dam GM, et al. Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe. Circulation. 2009;119(20):e534\u20136. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.821389 .","journal-title":"Circulation"},{"issue":"33","key":"953_CR16","doi-asserted-by":"publisher","first-page":"34776","DOI":"10.1074\/jbc.M310814200","volume":"279","author":"K Oorni","year":"2004","unstructured":"Oorni K, Sneck M, Bromme D, et al. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro. J Biol Chem. 2004;279(33):34776\u201384. https:\/\/doi.org\/10.1074\/jbc.M310814200 .","journal-title":"J Biol Chem"},{"issue":"3","key":"953_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/snuc.2003.127307","volume":"33","author":"PE Kinahan","year":"2003","unstructured":"Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography\/computed tomography scanners. Semin Nucl Med. 2003;33(3):166\u201379. https:\/\/doi.org\/10.1053\/snuc.2003.127307 .","journal-title":"Semin Nucl Med"},{"issue":"10","key":"953_CR18","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.2967\/jnumed.115.159798","volume":"56","author":"BA Blomberg","year":"2015","unstructured":"Blomberg BA, Thomassen A, De Jong PA, et al. Impact of personal characteristics and technical factors on quantification of sodium 18F-fluoride uptake in human arteries: prospective evaluation of healthy subjects. J Nucl Med. 2015;56(10):1534\u201340. https:\/\/doi.org\/10.2967\/jnumed.115.159798 .","journal-title":"J Nucl Med"},{"issue":"4","key":"953_CR19","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2967\/jnumed.115.154385","volume":"56","author":"W Chen","year":"2015","unstructured":"Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med. 2015;56(4):503\u20134. https:\/\/doi.org\/10.2967\/jnumed.115.154385 .","journal-title":"J Nucl Med"},{"issue":"1","key":"953_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11886-010-0150-5","volume":"13","author":"N Hiari","year":"2011","unstructured":"Hiari N, Rudd JH. FDG PET imaging and cardiovascular inflammation. Curr Cardiol Rep. 2011;13(1):43\u20138. https:\/\/doi.org\/10.1007\/s11886-010-0150-5 .","journal-title":"Curr Cardiol Rep"},{"issue":"8","key":"953_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrcardio.2014.80","volume":"11","author":"JM Tarkin","year":"2014","unstructured":"Tarkin JM, Joshi FR, Rudd JH. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014;11(8):443\u201357. https:\/\/doi.org\/10.1038\/nrcardio.2014.80 .","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"953_CR22","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2967\/jnumed.114.142596","volume":"56","author":"P Huet","year":"2015","unstructured":"\u2022\u2022 Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. J Nucl Med. 2015;56(4):552\u20139. A relevant summary, which describes the variability of 18F-FDG PET measurements. https:\/\/doi.org\/10.2967\/jnumed.114.142596 .","journal-title":"J Nucl Med"},{"issue":"4","key":"953_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2967\/jnumed.108.055616","volume":"50","author":"J Wykrzykowska","year":"2009","unstructured":"Wykrzykowska J, Lehman S, Williams G, Parker JA, Palmer MR, Varkey S, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET\/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med. 2009;50(4):563\u20138. https:\/\/doi.org\/10.2967\/jnumed.108.055616 .","journal-title":"J Nucl Med"},{"issue":"3","key":"953_CR24","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s12350-014-9884-6","volume":"21","author":"BA Blomberg","year":"2014","unstructured":"\u2022 Blomberg BA, Thomassen A, Takx RA, et al. Delayed (1)(8)F-fluorodeoxyglucose PET\/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. J Nucl Cardiol. 2014;21(3):588\u201397. This study shows that delayed 18F-FDG PET imaging improves quantification of atherosclerotic plaque inflammation. https:\/\/doi.org\/10.1007\/s12350-014-9884-6 .","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"953_CR25","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jacc.2007.05.024","volume":"50","author":"JH Rudd","year":"2007","unstructured":"Rudd JH, Myers KS, Bansilal S, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50(9):892\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2007.05.024 .","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"953_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","volume":"62","author":"A Tawakol","year":"2013","unstructured":"Tawakol A, Fayad ZA, Mogg R, Alon A, Klimas MT, Dansky H, et al. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study. J Am Coll Cardiol. 2013;62(10):909\u201317. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.066 .","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"953_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s11886-014-0521-4","volume":"16","author":"NV Joshi","year":"2014","unstructured":"Joshi NV, Vesey A, Newby DE, Dweck MR. Will 18F-sodium fluoride PET-CT imaging be the magic bullet for identifying vulnerable coronary atherosclerotic plaques? Curr Cardiol Rep. 2014;16(9):521. https:\/\/doi.org\/10.1007\/s11886-014-0521-4 .","journal-title":"Curr Cardiol Rep"},{"issue":"17","key":"953_CR28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.jacc.2011.12.037","volume":"59","author":"MR Dweck","year":"2012","unstructured":"Dweck MR, Chow MW, Joshi NV, et al. Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology. J Am Coll Cardiol. 2012;59(17):1539\u201348. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.037 .","journal-title":"J Am Coll Cardiol"},{"key":"953_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.atherosclerosis.2017.03.014","volume":"260","author":"M Oliveira-Santos","year":"2017","unstructured":"Oliveira-Santos M, Castelo-Branco M, Silva R, Gomes A, Chichorro N, Abrunhosa A, et al. Atherosclerotic plaque metabolism in high cardiovascular risk subjects\u2014a subclinical atherosclerosis imaging study with 18F-NaF PET-CT. Atherosclerosis. 2017;260:41\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.03.014 .","journal-title":"Atherosclerosis"},{"issue":"9","key":"953_CR30","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1007\/s00259-017-3728-y","volume":"44","author":"MF Bozkurt","year":"2017","unstructured":"Bozkurt MF, Virgolini I, Balogova S, Beheshti M, Rubello D, Decristoforo C, et al. Guideline for PET\/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA. Eur J Nucl Med Mol Imaging. 2017;44(9):1588\u2013601. https:\/\/doi.org\/10.1007\/s00259-017-3728-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"953_CR31","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s002590050034","volume":"27","author":"JC Reubi","year":"2000","unstructured":"Reubi JC, Schar JC, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27(3):273\u201382. https:\/\/doi.org\/10.1007\/s002590050034 .","journal-title":"Eur J Nucl Med"},{"issue":"1","key":"953_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11307-015-0873-1","volume":"18","author":"P Rinne","year":"2016","unstructured":"Rinne P, Hellberg S, Kiugel M, Virta J, Li XG, K\u00e4kel\u00e4 M, et al. Comparison of somatostatin receptor 2-targeting PET tracers in the detection of mouse atherosclerotic plaques. Mol Imaging Biol. 2016;18(1):99\u2013108. https:\/\/doi.org\/10.1007\/s11307-015-0873-1 .","journal-title":"Mol Imaging Biol"},{"issue":"14","key":"953_CR33","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.jacc.2017.01.060","volume":"69","author":"JM Tarkin","year":"2017","unstructured":"Tarkin JM, Joshi FR, Evans NR, Chowdhury MM, Figg NL, Shah AV, et al. Detection of atherosclerotic inflammation by 68Ga-DOTATATE PET compared to [18F]FDG PET imaging. J Am Coll Cardiol. 2017;69(14):1774\u201391. https:\/\/doi.org\/10.1016\/j.jacc.2017.01.060 .","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"953_CR34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s00259-012-2123-y","volume":"39","author":"L Kabasakal","year":"2012","unstructured":"Kabasakal L, Demirci E, Ocak M, Decristoforo C, Araman A, Ozsoy Y, et al. Comparison of (6)(8)Ga-DOTATATE and (6)(8)Ga-DOTANOC PET\/CT imaging in the same patient group with neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2012;39(8):1271\u20137. https:\/\/doi.org\/10.1007\/s00259-012-2123-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"953_CR35","doi-asserted-by":"publisher","first-page":"618","DOI":"10.7150\/thno.11251","volume":"5","author":"HJ Wester","year":"2015","unstructured":"Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F, et al. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics. 2015;5(6):618\u201330. https:\/\/doi.org\/10.7150\/thno.11251 .","journal-title":"Theranostics"},{"issue":"11","key":"953_CR36","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","volume":"52","author":"E Gourni","year":"2011","unstructured":"Gourni E, Demmer O, Schottelius M, D\u2019Alessandria C, Schulz S, Dijkgraaf I, et al. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med. 2011;52(11):1803\u201310. https:\/\/doi.org\/10.2967\/jnumed.111.098798 .","journal-title":"J Nucl Med"},{"issue":"12","key":"953_CR37","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jcmg.2015.09.008","volume":"8","author":"JT Thackeray","year":"2015","unstructured":"\u2022\u2022 Thackeray JT, Derlin T, Haghikia A, Napp LC, Wang Y, Ross TL, et al. Molecular imaging of the chemokine receptor CXCR4 after acute myocardial infarction. JACC Cardiovasc Imaging. 2015;8(12):1417\u201326. This study shows, that PET imaging with 68Ga-pentixafor allows for identifying CXCR4 receptor upregulation in the infarcted region in patient after acut myocardial infarction. https:\/\/doi.org\/10.1016\/j.jcmg.2015.09.008 .","journal-title":"JACC Cardiovasc Imaging"},{"key":"953_CR38","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Weiberg D, Thackeray JT, Daum G et al. Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using 68Ga-pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden. J Nucl Med. 2017. An essentail trial which shows that arterial wall 68Ga-Pentixafor uptake is significantly associated with surrogate hallmarks of atherosclerosis and is linked to the presence of cardiovascular risk factors.","DOI":"10.2967\/jnumed.117.196485"},{"issue":"3319","key":"953_CR39","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/131839b0","volume":"131","author":"A Jab\u0142o\u0144ski","year":"1933","unstructured":"Jab\u0142o\u0144ski A. Efficiency of anti-Stokes fluorescence in dyes. Nature. 1933;131(3319):839\u201340. https:\/\/doi.org\/10.1038\/131839b0 .","journal-title":"Nature"},{"key":"953_CR40","doi-asserted-by":"publisher","unstructured":"Hong G, Antaris AL, Dai H. Near-infrared fluorophores for biomedical imaging. Nat Biomed Eng. 2017;1(1) https:\/\/doi.org\/10.1038\/s41551-016-0010 .","DOI":"10.1038\/s41551-016-0010"},{"issue":"4","key":"953_CR41","doi-asserted-by":"publisher","first-page":"041303","DOI":"10.1117\/1.2953185","volume":"13","author":"EM Sevick-Muraca","year":"2008","unstructured":"Sevick-Muraca EM, Rasmussen JC. Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt. 2008;13(4):041303. https:\/\/doi.org\/10.1117\/1.2953185 .","journal-title":"J Biomed Opt"},{"issue":"2","key":"953_CR42","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1148\/radiol.2242011589","volume":"224","author":"U Mahmood","year":"2002","unstructured":"Mahmood U, Tung CH, Tang Y, Weissleder R. Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice. Radiology. 2002;224(2):446\u201351. https:\/\/doi.org\/10.1148\/radiol.2242011589 .","journal-title":"Radiology"},{"issue":"3","key":"953_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.106.654913","volume":"115","author":"E Aikawa","year":"2007","unstructured":"Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, Aikawa M, et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007;115(3):377\u201386. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.654913 .","journal-title":"Circulation"},{"issue":"17","key":"953_CR44","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIRCULATIONAHA.106.660340","volume":"115","author":"FA Jaffer","year":"2007","unstructured":"Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115(17):2292\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.660340 .","journal-title":"Circulation"},{"issue":"12","key":"953_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1364\/OL.26.000893","volume":"26","author":"V Ntziachristos","year":"2001","unstructured":"Ntziachristos V, Weissleder R. Experimental three-dimensional fluorescence reconstruction of diffuse media by use of a normalized Born approximation. Opt Lett. 2001;26(12):893\u20135. https:\/\/doi.org\/10.1364\/OL.26.000893 .","journal-title":"Opt Lett"},{"issue":"10","key":"953_CR46","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1161\/ATVBAHA.109.193086","volume":"29","author":"M Nahrendorf","year":"2009","unstructured":"Nahrendorf M, Waterman P, Thurber G, Groves K, Rajopadhye M, Panizzi P, et al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol. 2009;29(10):1444\u201351. https:\/\/doi.org\/10.1161\/ATVBAHA.109.193086 .","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"953_CR47","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1364\/BOE.5.001664","volume":"5","author":"B Li","year":"2014","unstructured":"Li B, Maafi F, Berti R, Pouliot P, Rh\u00e9aume E, Tardif JC, et al. Hybrid FMT-MRI applied to in vivo atherosclerosis imaging. Biomed Opt Express. 2014;5(5):1664\u201376. https:\/\/doi.org\/10.1364\/BOE.5.001664 .","journal-title":"Biomed Opt Express"},{"issue":"23","key":"953_CR48","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1161\/01.CIR.0000017860.20619.23","volume":"105","author":"J Chen","year":"2002","unstructured":"Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105(23):2766\u201371. https:\/\/doi.org\/10.1161\/01.CIR.0000017860.20619.23 .","journal-title":"Circulation"},{"issue":"1","key":"953_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCULATIONAHA.106.619056","volume":"114","author":"JO Deguchi","year":"2006","unstructured":"Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114(1):55\u201362. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.619056 .","journal-title":"Circulation"},{"issue":"1","key":"953_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.105.561449","volume":"113","author":"E Lutgens","year":"2006","unstructured":"Lutgens E, Lutgens SP, Faber BC, Heeneman S, Gijbels MM, de Winther MP, et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006;113(1):98\u2013107. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.561449 .","journal-title":"Circulation"},{"issue":"1","key":"953_CR51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.atherosclerosis.2013.11.040","volume":"232","author":"C Tan","year":"2014","unstructured":"Tan C, Liu Y, Li W, Deng F, Liu X, Wang X, et al. Associations of matrix metalloproteinase-9 and monocyte chemoattractant protein-1 concentrations with carotid atherosclerosis, based on measurements of plaque and intima-media thickness. Atherosclerosis. 2014;232(1):199\u2013203. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.040 .","journal-title":"Atherosclerosis"},{"issue":"11","key":"953_CR52","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1113\/EP085567","volume":"101","author":"AC Newby","year":"2016","unstructured":"Newby AC. Metalloproteinase production from macrophages\u2014a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction. Exp Physiol. 2016;101(11):1327\u201337. https:\/\/doi.org\/10.1113\/EP085567 .","journal-title":"Exp Physiol"},{"issue":"2","key":"953_CR53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2009.09.071","volume":"209","author":"L Rodriguez-Menocal","year":"2010","unstructured":"Rodriguez-Menocal L, Wei Y, Pham SM, St-Pierre M, Li S, Webster K, et al. A novel mouse model of in-stent restenosis. Atherosclerosis. 2010;209(2):359\u201366. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.09.071 .","journal-title":"Atherosclerosis"},{"issue":"43","key":"953_CR54","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1093\/eurheartj\/ehv349","volume":"36","author":"P Libby","year":"2015","unstructured":"\u2022\u2022 Libby P, Pasterkamp G. Requiem for the \u2018vulnerable plaque\u2019. Eur Heart J. 2015;36(43):2984\u20137. A relevant review, which describes the reshaped course of atherosclerosis due to current medical regime. https:\/\/doi.org\/10.1093\/eurheartj\/ehv349 .","journal-title":"Eur Heart J"},{"issue":"21","key":"953_CR55","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1161\/01.CIR.101.21.2450","volume":"101","author":"O Tricot","year":"2000","unstructured":"Tricot O, Mallat Z, Heymes C, Belmin J, Leseche G, Tedgui A. Relation between endothelial cell apoptosis and blood flow direction in human atherosclerotic plaques. Circulation. 2000;101(21):2450\u20133. https:\/\/doi.org\/10.1161\/01.CIR.101.21.2450 .","journal-title":"Circulation"},{"issue":"5","key":"953_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00101-002-0290-0","volume":"51","author":"T Spiegel Von","year":"2002","unstructured":"Von Spiegel T, Scholz M, Wietasch G, et al. Perioperative monitoring of indocyanine green clearance and plasma disappearance rate in patients undergoing liver transplantation. Anaesthesist. 2002;51(5):359\u201366. https:\/\/doi.org\/10.1007\/s00101-002-0290-0 .","journal-title":"Anaesthesist"},{"issue":"3","key":"953_CR57","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00000542-200703000-00013","volume":"106","author":"JM Maarek","year":"2007","unstructured":"Maarek JM, Holschneider DP, Rubinstein EH. Fluorescence dilution technique for measurement of cardiac output and circulating blood volume in healthy human subjects. Anesthesiology. 2007;106(3):491\u20138. https:\/\/doi.org\/10.1097\/00000542-200703000-00013 .","journal-title":"Anesthesiology"},{"issue":"2","key":"953_CR58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.ajo.2014.04.021","volume":"158","author":"CE Pang","year":"2014","unstructured":"Pang CE, Shah VP, Sarraf D, Freund KB. Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy. Am J Ophthalmol. 2014;158(2):362\u201371 e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.04.021 .","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"953_CR59","first-page":"1286","volume":"39","author":"S Yoneya","year":"1998","unstructured":"Yoneya S, Saito T, Komatsu Y, Koyama I, Takahashi K, Duvoll-Young J. Binding properties of indocyanine green in human blood. Invest Ophthalmol Vis Sci. 1998;39(7):1286\u201390.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"953_CR60","doi-asserted-by":"publisher","first-page":"3036","DOI":"10.1002\/art.38175","volume":"65","author":"SG Werner","year":"2013","unstructured":"Werner SG, Langer HE, Schott P, Bahner M, Schwenke C, Lind-Albrecht G, et al. Indocyanine green-enhanced fluorescence optical imaging in patients with early and very early arthritis: a comparative study with magnetic resonance imaging. Arthritis Rheum. 2013;65(12):3036\u201344. https:\/\/doi.org\/10.1002\/art.38175 .","journal-title":"Arthritis Rheum"},{"issue":"84","key":"953_CR61","doi-asserted-by":"publisher","first-page":"84ra45","DOI":"10.1126\/scitranslmed.3001577","volume":"3","author":"C Vinegoni","year":"2011","unstructured":"Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, et al. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011;3(84):84ra45. https:\/\/doi.org\/10.1126\/scitranslmed.3001577 .","journal-title":"Sci Transl Med"},{"issue":"9","key":"953_CR62","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.jcmg.2016.01.034","volume":"9","author":"JW Verjans","year":"2016","unstructured":"\u2022 Verjans JW, Osborn EA, Ughi GJ, Calfon Press MA, Hamidi E, Antoniadis AP, et al. Targeted near-infrared fluorescence imaging of atherosclerosis: clinical and intracoronary evaluation of indocyanine green. JACC Cardiovasc Imaging. 2016;9(9):1087\u201395. The first-in-human study of indocyanine green, which targets carotid plaques exhibiting decreased endothelial integrity. https:\/\/doi.org\/10.1016\/j.jcmg.2016.01.034 .","journal-title":"JACC Cardiovasc Imaging"},{"issue":"18","key":"953_CR63","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1161\/CIRCULATIONAHA.108.785881","volume":"118","author":"FA Jaffer","year":"2008","unstructured":"Jaffer FA, Vinegoni C, John MC, Aikawa E, Gold HK, Finn AV, et al. Real-time catheter molecular sensing of inflammation in proteolytically active atherosclerosis. Circulation. 2008;118(18):1802\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.785881 .","journal-title":"Circulation"},{"issue":"25","key":"953_CR64","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1016\/j.jacc.2011.02.036","volume":"57","author":"FA Jaffer","year":"2011","unstructured":"Jaffer FA, Calfon MA, Rosenthal A, Mallas G, Razansky RN, Mauskapf A, et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J Am Coll Cardiol. 2011;57(25):2516\u201326. https:\/\/doi.org\/10.1016\/j.jacc.2011.02.036 .","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"953_CR65","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","volume":"118","author":"G Nakazawa","year":"2008","unstructured":"Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation. 2008;118(11):1138\u201345. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.762047 .","journal-title":"Circulation"},{"issue":"1","key":"953_CR66","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","volume":"48","author":"M Joner","year":"2006","unstructured":"Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193\u2013202. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.042 .","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"953_CR67","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","volume":"375","author":"KH Bonaa","year":"2016","unstructured":"Bonaa KH, Mannsverk J, Wiseth R, et al. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375(13):1242\u201352. https:\/\/doi.org\/10.1056\/NEJMoa1607991 .","journal-title":"N Engl J Med"},{"issue":"6","key":"953_CR68","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.jcmg.2008.06.007","volume":"1","author":"GJ Tearney","year":"2008","unstructured":"Tearney GJ, Waxman S, Shishkov M, Vakoc BJ, Suter MJ, Freilich MI, et al. Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. JACC Cardiovasc Imaging. 2008;1(6):752\u201361. https:\/\/doi.org\/10.1016\/j.jcmg.2008.06.007 .","journal-title":"JACC Cardiovasc Imaging"},{"issue":"12","key":"953_CR69","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/nm.2555","volume":"17","author":"H Yoo","year":"2011","unstructured":"Yoo H, Kim JW, Shishkov M, Namati E, Morse T, Shubochkin R, et al. Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo. Nat Med. 2011;17(12):1680\u20134. https:\/\/doi.org\/10.1038\/nm.2555 .","journal-title":"Nat Med"},{"issue":"2","key":"953_CR70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10554-014-0556-z","volume":"31","author":"GJ Ughi","year":"2015","unstructured":"Ughi GJ, Verjans J, Fard AM, Wang H, Osborn E, Hara T, et al. Dual modality intravascular optical coherence tomography (OCT) and near-infrared fluorescence (NIRF) imaging: a fully automated algorithm for the distance-calibration of NIRF signal intensity for quantitative molecular imaging. Int J Cardiovasc Imaging. 2015;31(2):259\u201368. https:\/\/doi.org\/10.1007\/s10554-014-0556-z .","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"953_CR71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/CIRCINTERVENTIONS.114.001498","volume":"7","author":"S Lee","year":"2014","unstructured":"\u2022 Lee S, Lee MW, Cho HS, Song JW, Nam HS, Oh DJ, et al. Fully integrated high-speed intravascular optical coherence tomography\/near-infrared fluorescence structural\/molecular imaging in vivo using a clinically available near-infrared fluorescence-emitting indocyanine green to detect inflamed lipid-rich atheromata in coronary-sized vessels. Circ Cardiovasc Interv. 2014;7(4):560\u20139. This study shows, that an integrated OCT-NIRF catheter using indocyanine green is able to accurately identify lipid-rich plaqes in coronary-sized vessels in rabbits. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.114.001498 .","journal-title":"Circ Cardiovasc Interv"},{"issue":"37","key":"953_CR72","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1093\/eurheartj\/ehv726","volume":"37","author":"S Kim","year":"2016","unstructured":"Kim S, Lee MW, Kim TS, Song JW, Nam HS, Cho HS, et al. Intracoronary dual-modal optical coherence tomography-near-infrared fluorescence structural-molecular imaging with a clinical dose of indocyanine green for the assessment of high-risk plaques and stent-associated inflammation in a beating coronary artery. Eur Heart J. 2016;37(37):2833\u201344. https:\/\/doi.org\/10.1093\/eurheartj\/ehv726 .","journal-title":"Eur Heart J"},{"issue":"4","key":"953_CR73","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1364\/BOE.6.001363","volume":"6","author":"H Wang","year":"2015","unstructured":"Wang H, Gardecki JA, Ughi GJ, Jacques PV, Hamidi E, Tearney GJ. Ex vivo catheter-based imaging of coronary atherosclerosis using multimodality OCT and NIRAF excited at 633 nm. Biomed Opt Express. 2015;6(4):1363\u201375. https:\/\/doi.org\/10.1364\/BOE.6.001363 .","journal-title":"Biomed Opt Express"},{"issue":"11","key":"953_CR74","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.jcmg.2015.11.020","volume":"9","author":"GJ Ughi","year":"2016","unstructured":"\u2022 Ughi GJ, Wang H, Gerbaud E, Gardecki JA, Fard AM, Hamidi E, et al. Clinical characterization of coronary atherosclerosis with dual-modality OCT and near-infrared autofluorescence imaging. JACC Cardiovasc Imaging. 2016;9(11):1304\u201314. This study demonstrates the feasibilty of the dual-modality OCT\/NIRAF (near-infrared autofluorescence) catheter to detect high-risk plaques in patients with coronary artery disease. https:\/\/doi.org\/10.1016\/j.jcmg.2015.11.020 .","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-018-0953-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0953-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-018-0953-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T20:13:47Z","timestamp":1570738427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-018-0953-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["953"],"URL":"https:\/\/doi.org\/10.1007\/s11886-018-0953-3","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"12 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Bart de Keizer, B\u00e9la Merkely, Pim de Jong, Tim Leiner, and Richard A.P. Takx declare that they have no conflict of interest.Csilla Celeng reports grant support from the European Association of Cardiovascular Imaging (EACVI).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"11"}}